Korlyns Therapeutics Limited is a UK-based limited company established in 2007, currently operating under Reg: 06215455. The company specializes in the development and commercialization of innovative pharmaceutical products, primarily focused on oncology and immunology. Korlyns operates as a contract development and manufacturing organization (CDMO) and a research-driven pharmaceutical company. The company’s core business encompasses custom synthesis, preclinical and clinical trial material manufacturing, and the production of active pharmaceutical ingredients (APIs). Korlyns has established manufacturing facilities across Europe, including a significant presence in Ireland and Germany, ensuring a robust supply chain and regulatory compliance. Currently, Korlyns Therapeutics focuses on providing services to global pharmaceutical companies, including process development, analytical method development, and scale-up manufacturing. The company actively participates in international conferences and trade shows related to pharmaceutical science and technology. Korlyns has a dedicated team of scientists and engineers with expertise in complex chemistry and drug formulation. The company’s international presence is facilitated through strategic partnerships and a global network of distributors. Korlyns Therapeutics is currently rated as a Skilled Worker with an A rating, indicating a strong commitment to professional development and contributing to the UK economy. SIC codes include: - 46460 (Wholesale of pharmaceutical goods) and - 46461 (Pharmaceutical manufacturing) and - 46462 (Pharmaceutical distribution).

Korlyns Therapeutics Limited is a UK-based limited company established in 2007, currently operating under Reg: 06215455. The company specializes in the development and commercialization of innovative pharmaceutical products, primarily focused on oncology and immunology. Korlyns operates as a contract development and manufacturing organization (CDMO) and a research-driven pharmaceutical company. The company’s core business encompasses custom synthesis, preclinical and clinical trial material manufacturing, and the production of active pharmaceutical ingredients (APIs). Korlyns has established manufacturing facilities across Europe, including a significant presence in Ireland and Germany, ensuring a robust supply chain and regulatory compliance. Currently, Korlyns Therapeutics focuses on providing services to global pharmaceutical companies, including process development, analytical method development, and scale-up manufacturing. The company actively participates in international conferences and trade shows related to pharmaceutical science and technology. Korlyns has a dedicated team of scientists and engineers with expertise in complex chemistry and drug formulation. The company’s international presence is facilitated through strategic partnerships and a global network of distributors. Korlyns Therapeutics is currently rated as a Skilled Worker with an A rating, indicating a strong commitment to professional development and contributing to the UK economy. SIC codes include: - 46460 (Wholesale of pharmaceutical goods) and - 46461 (Pharmaceutical manufacturing) and - 46462 (Pharmaceutical distribution).